Table 1.
The total and differential leucocytic counts in the BALF pellets of the control and all experimental groups.
Groups | Total cells count × 105 | Lymphocytes % | Neutrophils % | Macrophages % | Eosinophils % |
---|---|---|---|---|---|
Control | 4.48 ± 0.33 | 13.25 ± 0.88 | 2.92 ± 0.37 | 83.17 ± 6.9 | 0.55 ± 0.05 |
ENT | 4.46 ± 0.46 | 11.88 ± 2.02 | 2.87 ± 0.12 | 84.63 ± 3.59 | 0.49 ± 0.09 |
VAL | 4.46 ± 0.49 | 11.6 ± 1.93 | 2.9 ± 0.44 | 84.11 ± 5.61 | 0.51 ± 0.08 |
CP | 12.8 ± 0.7* | 5.47 ± 1.29* | 45.3 ± 3.08* | 43.2 ± 6.49* | 5.15 ± 0.65* |
ENT + CP | 4.8 ± 0.49# | 9.63 ± 0.59*# | 10.9 ± 1.12*# | 77.9 ± 6.77# | 1.22 ± 0.16# |
VAL + CP | 5.85 ± 0.96# | 9.41 ± 0.96*# | 13.63 ± 2.32*# | 74.5 ± 7.48# | 1.84 ± 0.27*# |
Data are presented as the mean ± SD (One-way ANOVA followed by Tukey’s multiple comparison test; *P < 0.05, versus the control group; #P < 0.05, versus the CP-treated group).